αMT (Alpha-methyltryptamine)
Alpha-methyltryptamine (AMT) is a long-acting tryptamine with mixed psychedelic, stimulant, and entactogenic effects. Originally investigated as an antidepressant in the Soviet Union (marketed as Indopan), it later re-emerged as a recreational research chemical. Its alpha-methyl group confers monoamine-releasing and MAOI activity and a long duration; it has been implicated in deaths, often involving drug interactions.
01 Overview
AMT was studied clinically as an antidepressant in the 1960s at low doses. At the higher doses used recreationally it produces a mixture of psychedelic, stimulant, and MDMA-like effects lasting 12-24 hours. The alpha-methyl substitution slows metabolism and gives the compound monoamine oxidase inhibitory properties.
That MAOI activity is the key hazard: combining AMT with SSRIs, other MAOIs, or serotonergic drugs risks serotonin toxicity, and several fatalities have involved such interactions or high doses. The long duration compounds the risk. It was placed in US Schedule I in 2003.
02 Mechanism
Non-selective monoamine releaser and reuptake inhibitor with serotonin 5-HT2A agonism and reversible monoamine oxidase inhibition; the alpha-methyl group slows metabolism and prolongs effects.
03 Dosing
| Tier | Dose | Route | Notes |
|---|---|---|---|
| Light | 10–20 mg | Oral | Anecdotal; stimulant-leaning at lower doses. |
| Common | 20–40 mg | Oral | Anecdotal; full psychedelic/entactogenic effects, very long duration. |
04 Effects
| Effect | Magnitude | Evidence | |
|---|---|---|---|
| Entactogenic / stimulant effectsMDMA-like emotional openness combined with stimulation, per user reports. | Variable | Anecdotal | |
| Psychedelic effectsVisual and cognitive alteration at higher doses over a long duration. | Dose-dependent | Anecdotal |
05 Side effects
| Effect | Severity | Frequency | Evidence | Countermeasures |
|---|---|---|---|---|
| Nausea and appetite lossNausea, especially during onset, and appetite suppression. | Mild | Common | Anecdotal | |
| Prolonged insomnia and anxietyThe long stimulant duration frequently causes extended wakefulness and anxiety. | Moderate | Common | Anecdotal | |
| Serotonin toxicity from interactionsMAOI activity makes combinations with serotonergic drugs dangerous; deaths have occurred. | Life-threatening | Reported in fatalities | Observational |